Exchange: NYSE·Updated 07:30 PM EDT
Latest Earnings Results: Q2 '26

Reported: Aug 10

Estimated EPS

-$0.08

Reported EPS

-$0.19

Surprise

-126.64%

Estimated Rev

$628.66M

Reported Rev

$613.2M

Surprise

-2.46%

Accendra Health updated its full year 2026 outlook, projecting revenue of $2.45 billion to $2.55 billion, adjusted EBITDA of $300 million to $320 million, and free cash flow as breakeven to slightly positive.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

Investor Presentation10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.01
--
--
N/A
Q2 '26
-$0.08
-$0.19
-126.64%
MISSED
Q1 '26
-$0.10
-$0.04
59.31%
BEAT
Q4 '25
$0.22
$0.21
-5.05%
MISSED
Q3 '25
$0.67
$0.25
-62.96%
MISSED

Advertisement|Remove ads.